查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490322

医疗外骨骼市场：行业趋势和全球预测（-2035）-依目标地点、操作模式、外骨骼形式、移动性、最终用户和主要地理区域

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 224 Pages | 商品交期: 最快1-2个工作天内

价格

2024年医疗外骨骼市场规模预估为19亿美元，2024-2035年预测期间复合年增长率预估为20.8%。

医疗外骨骼是可穿戴机器人设备，专为帮助患有运动障碍的人而设计，利用机械、电子和电脑控制系统的融合来增强和完善用户的运动。这些设备通常针对受伤害或残疾影响的身体特定区域，与轮椅和拐杖等传统辅助设备不同。一些动力外骨骼技术透过整合致动器和感测器来增强使用者的肌肉力量和耐力，从而提供主动运动辅助。医疗外骨骼的潜力巨大，引起了许多急需行动辅助的患者群体的共鸣。尤其是神经系统疾病，是一项重大的公共卫生课题，影响着全世界超过十亿人。

儘管有大量人口受到行动障碍的困扰，但外骨骼市场仍然相对小众，儘管慢慢获得关注。这是由于多种因素造成的，包括与外骨骼技术相关的成本不断上升以及患者和医疗保健提供者普遍缺乏认识。然而，随着技术的不断进步和意识的提高，医疗外骨骼市场有望扩大，并有望改善需要行动辅助的人们的可及性和生活品质。事实上，多家公司正在率先开发外骨骼技术，这些技术融合了控制器和软体应用程式等先进功能，允许用户和临床医生设定目标、微调辅助水平和客製化康復，这使您可以仔细检查。符合您计划的运动模式。

本报告调查了全球医疗外骨骼市场，并提供了市场概况，以及依目标区域、操作方式、外骨骼形式、移动性、最终用户、主要区域和市场趋势划分的趋势。 。

目录

第1章 前言

第2章 研究方法

第3章 经济和其他专案特定考虑因素

第4章 执行摘要

第5章 简介

第6章 医疗外骨骼：市场状况

  • 章节概述
  • 医疗外骨骼：市场情势
  • 医疗外骨骼：开发商、现状

第7章 医用外骨骼：产品竞争分析

  • 章节概述
  • 假设和关键参数
  • 调查方法
  • 医疗外骨骼：产品竞争分析

第8章 外骨骼开发公司：详细公司简介

  • 章节概述
  • CYBERDYNE
  • Ekso Bionics
  • ExoAtlet
  • Fourier Intelligence
  • Gloreha
  • Guangzhou Yikang
  • Hexar Humancare
  • Hocoma
  • Panasonic
  • Tyromotion

第9章 外骨骼开发公司：公司简介列表

  • 章节概述
  • Bionic Yantra
  • MediTouch
  • Milebot Robotics
  • Myomo
  • Neofect
  • NextStep Robotics
  • ReWalk Robotics
  • Rex Bionics
  • Roam Robotics
  • Trexo Robotics
  • U&O Technologies

第10章 医疗外骨骼：伙伴关係与协作

  • 章节概述
  • 合作模式
  • 医疗外骨骼：合作伙伴和协作列表

第11章 专利分析

第12章 蓝海战略

第13章 市场影响分析：驱动因素、限制因素、机会、课题

  • 章节概述
  • 市场驱动力
  • 市场限制
  • 市场机会
  • 市场课题
  • 结论

第14章 医疗外骨骼市场

  • 章节概述
  • 预测研究方法和主要假设
  • 医疗外骨骼市场、过去趋势（2018-2022）与预测（2023-2035）
  • 主要市场区隔
  • 动态仪表板

第15章 外骨骼市场，依目标区域

第16章 外骨骼市场，依营运模式

第17章 外骨骼市场，依形式

第18章 外骨骼市场，依移动性分类

第19章 外骨骼市场，依最终用户划分

第20章 外骨骼市场（依地区）

  • 章节概述
  • 预测研究方法和主要假设
  • 北美
  • 欧洲
  • 亚太地区
  • 其他地区
  • 数据三角测量和验证

第21章 结论

第22章 高阶主管洞察

第23章 附录1蓝海策略与转型工具

第24章 附录2 表格数据

第25章 附录三 公司、组织名单

Product Code: RAU1028

Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered (Upper Body, Lower Body and Full Body), Mode of Operation (Powered, Passive and Hybrid), Form of Exoskeleton (Rigid and Soft), Mobility (Fixed / Supported and Mobile), End Users (Patients and Healthcare Providers), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)

The Medical Exoskeleton Market is valued at USD 1.90 billion in 2024 growing at a CAGR of 20.8% during the forecast period 2024-2035.

Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in on specific body parts affected by injury or disability, these devices diverge from conventional assistive tools like wheelchairs and crutches. Certain iterations of powered exoskeleton technology furnish active mobility assistance by amplifying the user's strength and stamina through the integration of actuators and sensors. The potential of medical exoskeletons is vast, resonating with a considerable patient demographic in dire need of mobility support. Neurological disorders, in particular, pose a formidable public health challenge, impacting over one billion individuals worldwide. Traumatic brain injury (TBI), as highlighted by the Lancet Neurology Commission, stands as a pervasive global concern afflicting 55 million people, while current estimates suggest a populace of 20.6 million grappling with spinal cord injury.

Despite the substantial population contending with mobility impairments, the exoskeleton market maintains a relatively niche status, albeit gradually garnering attention. This can be attributed to various factors, including the elevated costs associated with exoskeleton technology and a prevalent lack of awareness among both patients and healthcare providers. Nonetheless, with ongoing technological strides and heightened awareness, the medical exoskeleton market stands poised for expansion, offering the promise of enhanced accessibility and quality of life for those in need of mobility assistance. Indeed, several companies are spearheading the development of exoskeleton technology fused with advanced features such as controllers and software applications, empowering users and clinicians alike to establish goals, fine-tune assistance levels, and scrutinize movement patterns tailored to personalized rehabilitation plans.

Key Market Segments

Body Part Covered

  • Upper Extremity
  • Lower Extremity
  • Full Body

Mode of Operation

  • Powered
  • Passive
  • Hybrid

Form

  • Rigid
  • Soft

Mobility

  • Fixed / Supported
  • Mobile

End Users

  • Patients
  • Healthcare Providers

Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Research Coverage:

  • An insightful overview of exoskeleton industry, highlighting details on origin of exoskeletons. This chapter provides information on classification of exoskeleton, along with applications, features and limitations associated with exoskeleton. Further, it concludes with a discussion on future perspectives in this domain.
  • This overview provides insight into the current market landscape of medical exoskeletons, considering various parameters such as development status (commercialized and under development), body part coverage (upper extremity, lower extremity, and full body), mode of operation (powered, passive, and hybrid), exoskeleton form (rigid and soft exosuit), mobility (stationary and mobile), user-machine interface (including app-based, handheld controller, on-device buttons/control panels, and brain control), and advanced features (such as data capture, gamification, and customized assistance). Additionally, it addresses end users (patients, medical professionals, and researchers), patient age groups (pediatric to adolescent, adolescent to elderly), and exoskeleton settings (home/community and rehabilitation centers). It also touches on breakthrough device designations, exoskeleton technology/software, maximum weight, weight carrying capacity, and dimensions. Furthermore, it lists companies involved in medical exoskeleton development/commercialization, providing details on establishment year, company size, headquarters location, ownership, and additional services. Lastly, it highlights the most active companies in terms of medical exoskeleton offerings.
  • A comprehensive analysis of product competitiveness within the medical exoskeleton market, focusing on supplier strength (including years of experience, company size, and exoskeleton portfolio), product competitiveness (encompassing device mobility, exoskeleton form, operation mode, advanced features, user-machine interface, additional services, breakthrough designation, and development status), and target end users.
  • Comprehensive profiles of prominent medical exoskeleton companies selected based on the quantity and application scope of wearable exoskeletons in their product lineup. Each profile provides a succinct overview of the company, including establishment year, employee count, headquarters location, and leadership team details, along with insights into financial performance where applicable. Additionally, the profiles encompass information on the company's product range, recent advancements, and an informed perspective on future prospects.
  • Tabulated summaries of leading medical exoskeleton companies selected based on the quantity and application range of wearable exoskeletons in their product offerings. Each tabulated profile provides an overview of the company, detailing establishment year, employee count, headquarters location, and key leadership team members. Additionally, the profiles include information on the company's product portfolio.
  • A comprehensive analysis of the medical exoskeleton market's recent partnerships and collaborations established since 2017. This analysis considers various parameters, including the year of partnership, partnership type (such as mergers and acquisitions, product development and commercialization agreements, licensing agreements, service agreements, product development and manufacturing agreements, joint ventures, manufacturing and supply agreements, and product distribution agreements), partner type (industry and non-industry), business globalization trends, and the most active players. Additionally, it provides insights into the regional distribution of the companies engaged in these agreements.
  • A thorough examination of patents filed or granted for exoskeletons since 2016, encompassing diverse relevant factors such as patent type, application and publication years, geographical origins, applicant types, publication timelines, top CPC symbols, and key players in terms of the quantity of patents filed or granted. Additionally, it includes an in-depth patent benchmarking analysis.
  • An exhaustive examination of the present and prospective market through the lens of the Blue Ocean Strategy, providing a strategic roadmap for nascent medical exoskeleton enterprises to tap into uncontested market spaces. This guide encompasses thirteen strategic tools aimed at facilitating a transition towards a Blue Ocean strategy, enabling companies to secure a competitive advantage in the market.
  • A comprehensive examination of the factors influencing the expansion of the medical exoskeleton market. This analysis includes the identification and evaluation of significant drivers, potential limitations, emerging prospects, and current obstacles.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Medical Exoskeleton Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

  • Bionic Yantra

CYBERDYNE

  • Ekso Bionics
  • ExoAtlet
  • Fourier Intelligence
  • Gloreha
  • Guangzhou Yikang Medical Equipment
  • Hexar Humancare
  • Hocoma
  • MediTouch
  • Milebot Robotics
  • Myomo
  • Neofect
  • NextStep Robotics
  • Panasonic
  • ReWalk Robotics
  • Rex Bionics
  • Roam Robotics
  • Trexo Robotics
  • Tyromotion
  • U&O Technologies

TABLE OF CONTENTS

Table Of Contents

1. PREFACE

  • 1.1. Introduction
  • 1.2. Key Market Insights
  • 1.3. Scope of the Report
  • 1.4. Research Methodology
  • 1.5. Frequently Asked Questions
  • 1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

  • 2.1. Chapter Overview
  • 2.2. Research Assumptions
  • 2.3. Project Methodology
  • 2.4. Forecast Methodology
  • 2.5. Robust Quality Control
  • 2.6. Key Market Segmentations
  • 2.7. Key Considerations
    • 2.7.1. Demographics
    • 2.7.2. Economic Factors
    • 2.7.3. Government Regulations
    • 2.7.4. Supply Chain
    • 2.7.5. COVID Impact / Related Factors
    • 2.7.6. Market Access
    • 2.7.7. Healthcare Policies
    • 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 3.1. Chapter Overview
  • 3.2. Market Dynamics
    • 3.2.1. Time Period
      • 3.2.1.1. Historical Trends
      • 3.2.1.2. Current and Forecasted Estimates
    • 3.2.2. Currency Coverage
      • 3.2.2.1. Overview of Major Currencies Affecting the Market
      • 3.2.2.2. Impact of Currency Fluctuations on the Industry
    • 3.2.3. Foreign Exchange Impact
      • 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
      • 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
    • 3.2.4. Recession
      • 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 3.2.5. Inflation
      • 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

  • 5.1. Chapter Overview
  • 5.2. Overview of Exoskeleton
  • 5.3. History of Exoskeleton
  • 5.4. Classification of Exoskeleton
    • 5.4.1. Based on Body Part Supported
    • 5.4.2. Based on Form of Exoskeleton
    • 5.4.3. Based on Mode of Operation
    • 5.4.4 Based on Mobility
  • 5.5. Applications of Exoskeleton
  • 5.6. Features of Exoskeleton
  • 5.7. Limitations of Exoskeleton
  • 5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

  • 6.1. Chapter Overview
  • 6.2. Medical Exoskeleton: Overall Market Landscape
    • 6.2.1. Analysis by Status of Development
    • 6.2.2. Analysis by Type of Body Part Covered
    • 6.2.3. Analysis by Mode of Operation
    • 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
    • 6.2.5. Analysis by Form of Exoskeleton
    • 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
    • 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
    • 6.2.8. Analysis by Device Mobility
    • 6.2.9. Analysis by Mode of Operation and Device Mobility
    • 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
    • 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
    • 6.2.12. Analysis by User-Machine Interface
    • 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
    • 6.2.14. Analysis by Mode of Operation and User-Machine Interface
    • 6.2.15. Analysis by Availability of Advanced Features
    • 6.2.16. Analysis by End User
    • 6.2.17. Analysis by Patient Age Group
    • 6.2.18. Analysis by Exoskeleton Setting for Patients
    • 6.2.19. Analysis by Breakthrough Designation
  • 6.3. Medical Exoskeleton: Developer: Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis by Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Analysis by Company Size and Location of Headquarters
    • 6.3.5. Analysis by Company Ownership
    • 6.3.6. Analysis by Location of Headquarters and Company Ownership
    • 6.3.7. Analysis by Additional Services Offered
    • 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. MEDICAL EXOSKELETON: PRODUCT COMPETITIVENESS ANALYSIS

  • 7.1 Chapter Overview
  • 7.2. Assumptions and Key Parameters
  • 7.3. Methodology
  • 7.4. Medical Exoskeleton: Product Competitiveness Analysis
    • 7.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
      • 7.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
      • 7.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
      • 7.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
    • 7.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
      • 7.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
      • 7.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
      • 7.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
    • 7.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

8. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. CYBERDYNE
    • 8.2.1. Company Overview
    • 8.2.2. Financial Information
    • 8.2.3. Product Portfolio
    • 8.2.4 Recent Developments and Future Outlook
  • 8.3. Ekso Bionics
    • 8.3.1. Company Overview
    • 8.3.2. Financial Information
    • 8.3.3. Product Portfolio
    • 8.3.4 Recent Developments and Future Outlook
  • 8.4. ExoAtlet
    • 8.4.1. Company Overview
    • 8.4.2. Product Portfolio
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Fourier Intelligence
    • 8.5.1. Company Overview
    • 8.5.2. Product Portfolio
    • 8.5.3. Recent Developments and Future Outlook
  • 8.6. Gloreha
    • 8.6.1. Company Overview
    • 8.6.2. Product Portfolio
    • 8.6.3. Recent Developments and Future Outlook
  • 8.7. Guangzhou Yikang
    • 8.7.1. Company Overview
    • 8.7.2. Product Portfolio
    • 8.7.3. Recent Developments and Future Outlook
  • 8.8. Hexar Humancare
    • 8.8.1. Company Overview
    • 8.8.2. Product Portfolio
    • 8.8.3. Recent Developments and Future Outlook
  • 8.9. Hocoma
    • 8.9.1. Company Overview
    • 8.9.2. Product Portfolio
    • 8.9.3. Recent Developments and Future Outlook
  • 8.10. Panasonic
    • 8.10.1. Company Overview
    • 8.10.2. Financial Information
    • 8.10.3. Product Portfolio
    • 8.10.4. Recent Developments and Future Outlook
  • 8.11. Tyromotion
    • 8.11.1. Company Overview
    • 8.11.2. Product Portfolio
    • 8.11.3. Recent Developments and Future Outlook

9. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Bionic Yantra
  • 9.3. MediTouch
  • 9.4. Milebot Robotics
  • 9.5. Myomo
  • 9.6. Neofect
  • 9.7. NextStep Robotics
  • 9.8. ReWalk Robotics
  • 9.9. Rex Bionics
  • 9.10. Roam Robotics
  • 9.11. Trexo Robotics
  • 9.12. U&O Technologies

10. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

  • 10.1. Chapter Overview
  • 10.2. Partnership Models
  • 10.3. Medical Exoskeleton: List of Partnerships and Collaborations
    • 10.3.1. Analysis by Year of Partnership
    • 10.3.2. Analysis by Type of Partnership
    • 10.3.3. Analysis by Year and Type of Partnership
    • 10.3.4. Analysis by Type of Partner
    • 10.3.5. Analysis by Year of Partnership and Type of Partner
    • 10.3.6. Analysis by Purpose of Partnership
    • 10.3.7. Analysis by Geography
      • 10.3.7.1. Local and International Agreements
      • 10.3.7.2. Intracontinental and Intercontinental Agreements
      • 10.3.7.3. Most Active Players: Distribution by Number of Partnerships

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Exoskeleton: Patent Analysis
    • 11.3.1. Analysis by Patent Application Year
    • 11.3.2. Analysis by Patent Publication Year
    • 11.3.3. Analysis by Type of Patent and Patent Publication Year
    • 11.3.4. Analysis by Publication Time
    • 11.3.5. Analysis by Patent Jurisdiction
    • 11.3.6. Analysis by CPC symbols
    • 11.3.7. Analysis by Type of Applicant
    • 11.3.8. Leading Players: Analysis by Number of Patents
    • 11.3.9. Leading Patent Assignees: Analysis by Number of Patents
  • 11.4. Exoskeleton: Patent Benchmarking
    • 11.4.1. Analysis by Patent Characteristics
    • 11.4.2. Exoskeleton: Patent Valuation
  • 11.5. Leading Players by Number of Citations

12. BLUE OCEAN STRATEGY

  • 12.1. Overview of Blue Ocean Strategy
    • 12.1.1. Red Oceans
    • 12.1.2. Blue Oceans
    • 12.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
    • 12.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
      • 12.1.4.1. Strategy Canvas
      • 12.1.4.2. Pioneer-Migrator-Settler (PMS) Map
      • 12.1.4.3. Buyer Utility Map

13. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 13.1. Chapter Overview
  • 13.2. Market Drivers
  • 13.3. Market Restraints
  • 13.4. Market Opportunities
  • 13.5. Market Challenges
  • 13.6. Conclusion

14. MEDICAL EXOSKELETON MARKET

  • 14.1. Chapter Overview
  • 14.2. Forecast Methodology and Key Assumptions
  • 14.3. Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
    • 14.3.1. Scenario Analysis
  • 14.4. Key Market Segmentations
  • 14.5. Dynamic Dashboard

15. EXOSKELETON MARKET, BY BODY PART COVERED

  • 15.1. Chapter Overview
  • 15.2. Forecast Methodology and Key Assumptions
  • 15.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 15.6. Data Triangulation and Validation

16. EXOSKELETON MARKET, BY MODE OF OPERATION

  • 16.1. Chapter Overview
  • 16.2. Forecast Methodology and Key Assumptions
  • 16.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 16.6. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY THEIR FORM

  • 17.1. Chapter Overview
  • 17.2. Forecast Methodology and Key Assumptions
  • 17.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 17.5. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR MOBILITY

  • 18.1. Chapter Overview
  • 18.2. Forecast Methodology and Key Assumptions
  • 18.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 18.5. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY END USERS

  • 19.1. Chapter Overview
  • 19.2. Forecast Methodology and Key Assumptions
  • 19.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 19.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY GEOGRAPHY

  • 20.1. Chapter Overview
  • 20.2. Forecast Methodology and Key Assumptions
  • 20.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • 20.7. Data Triangulation and Validation

21. CONCLUSION

22. EXECUTIVE INSIGHTS

  • 22.1. Chapter Overview
  • 22.2. Spain-based Small Company
    • 22.2.1. Company Snapshot
    • 22.2.2. Interview Transcript: Co-Founder and Chief Executive Officer
  • 22.3. Japan-based Small Company
    • 22.3.1. Company Snapshot
    • 22.3.2. Interview Transcript: Director of Business Planning and Development
  • 22.4. US-based Small Company
    • 22.4.1. Company Snapshot
    • 22.4.2. Interview Transcript: Vice President of Sales and Marketing
  • 22.5. Canada-based Small Company
    • 22.5.1. Company Snapshot
    • 22.5.2. Interview Transcript: Marketing and Design Manager
  • 22.6. India-based Small Company
    • 22.6.1. Company Snapshot
    • 22.6.2. Interview Transcript: Founder and Director

23. APPENDIX 1: BLUE OCEAN STRATEGY AND SHIFT TOOLS

24. APPENDIX 2: TABULATED DATA

25. APPENDIX 3: LIST OF COMPANIES AND ORGANIZATION

List of Tables

  • Table 5.1 Contrasting Characteristics: Medical and Non-Medical Exoskeleton
  • Table 5.2 Degrees of Freedom in Each Joint of Lower Exoskeleton
  • Table 5.3 Contrasting Characteristics: Rigid and Soft Exoskeleton
  • Table 6.1 Medical Exoskeleton: Information on Status of Development, Type of Body Part Covered and Mode of Operation
  • Table 6.2 Medical Exoskeleton: Information on Form of Exoskeleton, Device Mobility and User-Machine Interface
  • Table 6.3 Medical Exoskeleton: Information on Advanced Features and End Users
  • Table 6.4 Medical Exoskeleton: Information on Patient Age Group, Exoskeleton Setting for Patients and Breakthrough Designation
  • Table 6.5 Medical Exoskeleton: Information on Technology / Software, Maximum Weight of Exoskeleton, Maximum Weight Carrying Capacity and Dimensions
  • Table 6.6 Medical Exoskeleton: List of Developers
  • Table 6.7 Medical Exoskeleton: Information on Additional Services Offered
  • Table 8.1 List of Medical Exoskeleton Companies Profiled
  • Table 8.2 CYBERDYNE: Company Snapshot
  • Table 8.3 CYBERDYNE: Medical Exoskeleton Portfolio
  • Table 8.4 CYBERDYNE: Recent Developments and Future Outlook
  • Table 8.5 Ekso Bionics: Company Snapshot
  • Table 8.6 Ekso Bionics: Medical Exoskeleton Portfolio
  • Table 8.7 Ekso Bionics: Recent Developments and Future Outlook
  • Table 8.8 ExoAtlet: Company Snapshot
  • Table 8.9 ExoAtlet: Medical Exoskeleton Portfolio
  • Table 8.10 ExoAtlet: Recent Developments and Future Outlook
  • Table 8.11 Fourier Intelligence: Company Snapshot
  • Table 8.12 Fourier Intelligence: Medical Exoskeleton Portfolio
  • Table 8.13 Fourier Intelligence: Recent Developments and Future Outlook
  • Table 8.14 Gloreha: Company Snapshot
  • Table 8.15 Gloreha: Medical Exoskeleton Portfolio
  • Table 8.16 Gloreha: Recent Developments and Future Outlook
  • Table 8.17 Guangzhou YiKang: Company Snapshot
  • Table 8.18 Guangzhou YiKang: Medical Exoskeleton Portfolio
  • Table 8.19 Guangzhou YiKang: Recent Developments and Future Outlook
  • Table 8.20 Hexar Humancare: Company Snapshot
  • Table 8.21 Hexar Humancare: Medical Exoskeleton Portfolio
  • Table 8.22 Hexar Humancare: Recent Developments and Future Outlook
  • Table 8.23 Hocoma: Company Snapshot
  • Table 8.24 Hocoma: Medical Exoskeleton Portfolio
  • Table 8.25 Hocoma: Recent Developments and Future Outlook
  • Table 8.26 Panasonic: Company Snapshot
  • Table 8.27 Panasonic: Medical Exoskeleton Portfolio
  • Table 8.28 Panasonic: Recent Developments and Future Outlook
  • Table 8.29 Tyromotion: Company Snapshot
  • Table 8.30 Tyromotion: Medical Exoskeleton Portfolio
  • Table 8.31 Tyromotion: Recent Developments and Future Outlook
  • Table 9.1 Bionic Yantra: Company Snapshot and Product Portfolio
  • Table 9.2 Bionic Yantra: Medical Exoskeleton Portfolio
  • Table 9.3 MediTouch: Company Snapshot
  • Table 9.4 MediTouch: Medical Exoskeleton Portfolio
  • Table 9.5 Milebot Robotics: Company Snapshot
  • Table 9.6 Milebot Robotics: Medical Exoskeleton Portfolio
  • Table 9.7 Milebot Robotics: Non- Medical Exoskeleton Portfolio
  • Table 9.8 Myomo: Company Snapshot
  • Table 9.9 Myomo: Medical Exoskeleton Portfolio
  • Table 9.10 Neofect: Company Snapshot
  • Table 9.11 Neofect: Medical Exoskeleton Portfolio
  • Table 9.12 NextStep Robotics: Company Snapshot
  • Table 9.13 NextStep Robotics: Medical Exoskeleton Portfolio
  • Table 9.14 ReWalk Robotics: Company Snapshot
  • Table 9.15 ReWalk Robotics: Medical Exoskeleton Portfolio
  • Table 9.16 REX Bionics: Company Snapshot
  • Table 9.17 REX Bionics: Medical Exoskeleton Portfolio
  • Table 9.18 Roam Robotics: Company Snapshot
  • Table 9.19 Roam Robotics: Medical Exoskeleton Portfolio
  • Table 9.20 Trexo Robotics: Company Snapshot
  • Table 9.21 Trexo Robotics: Medical Exoskeleton Portfolio
  • Table 9.22 U&O Technologies: Company Snapshot
  • Table 9.23 U&O Technologies: Medical Exoskeleton Portfolio
  • Table 10.1 Medical Exoskeleton: List of Partnerships and Collaborations
  • Table 11.1 Patent Analysis: Top CPC Sections
  • Table 11.2 Patent Analysis: Top CPC Symbols
  • Table 11.3 Patent Analysis: List of Top CPC Codes
  • Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 24.1 Medical Exoskeleton: Distribution by Status of Development
  • Table 24.2 Medical Exoskeleton: Distribution by Body Part Covered
  • Table 24.3 Medical Exoskeleton: Distribution by Mode of Operation
  • Table 24.4 Medical Exoskeleton: Distribution by Body Part Covered and Mode of Operation
  • Table 24.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
  • Table 24.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
  • Table 24.7 Medical Exoskeleton: Distribution by Body Part Covered and Form of Exoskeleton
  • Table 24.8 Medical Exoskeleton: Distribution by Device Mobility
  • Table 24.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
  • Table 24.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
  • Table 24.11 Medical Exoskeleton: Distribution by Body Part Covered and Device Mobility
  • Table 24.12 Medical Exoskeleton: Distribution by User-Machine Interface
  • Table 24.13 Medical Exoskeleton: Distribution by Body Part Covered and User-Machine Interface
  • Table 24.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
  • Table 24.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
  • Table 24.16 Medical Exoskeleton: Distribution by End User
  • Table 24.17 Medical Exoskeleton: Distribution by Patient Age Group
  • Table 24.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
  • Table 24.19 Medical Exoskeleton: Distribution by Breakthrough Designation
  • Table 24.20 Medical Exoskeleton Developers: Distribution by Year of Establishment
  • Table 24.21 Medical Exoskeleton Developers: Distribution by Company Size
  • Table 24.22 Medical Exoskeleton Developers: Distribution by Company Size and Employee Count
  • Table 24.23 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Region)
  • Table 24.24 Medical Exoskeleton Developers: Distribution by Location of Headquarters (Country)
  • Table 24.25 Medical Exoskeleton Developers: Distribution by Company Size and Location of Headquarters
  • Table 24.26 Medical Exoskeleton Developers: Distribution by Company Ownership
  • Table 24.27 Medical Exoskeleton Developers: Distribution by Location of Headquarters and Company Ownership
  • Table 24.28 Medical Exoskeleton Developers: Distribution by Additional Services Offered
  • Table 24.29 Most Active Players: Distribution by Number of Medical Exoskeleton
  • Table 24.30 CYBERDYNE: Annual Revenues, FY2019 - FY2023 (JPY Billion)
  • Table 24.31 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
  • Table 24.32 Ekso Bionics: Annual Revenues, 2018 - Q1 2023 (USD Billion)
  • Table 24.33 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
  • Table 24.34 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
  • Table 24.35 Partnerships and Collaborations: Distribution by Year of Partnership
  • Table 24.36 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 24.37 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Table 24.38 Partnerships and Collaborations: Distribution by Type of Partner
  • Table 24.39 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
  • Table 24.40 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Table 24.41 Partnerships and Collaborations: Local and International Agreements
  • Table 24.42 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Table 24.43 Most Active Players: Distribution by Number of Partnerships
  • Table 24.44 Patent Analysis: Distribution by Type of Patent
  • Table 24.45 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016- 2022
  • Table 24.46 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
  • Table 24.47 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
  • Table 24.48 Patent Analysis: Distribution by Publication Time
  • Table 24.49 Patent Analysis: Distribution by Patent Jurisdiction (Region)
  • Table 24.50 Patent Analysis: Distribution by Patent Jurisdiction (Country)
  • Table 24.51 Patent Analysis: Distribution by CPC Symbols
  • Table 24.52 Patent Analysis: Distribution by Type of Applicant
  • Table 24.53 Leading Industry Players: Distribution by Number of Patents
  • Table 24.54 Leading Non-Industry Players: Distribution by Number of Patents
  • Table 24.55 Leading Individual Assignees: Distribution by Number of Patents
  • Table 24.56 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
  • Table 24.57 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
  • Table 24.58 Patent Analysis: Distribution by Patent Age
  • Table 24.59 Patent Analysis: Patent Valuation
  • Table 24.60 Medical Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
  • Table 24.61 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Base Scenario (USD Million)
  • Table 24.62 Medical Exoskeleton Market, Forecasted Estimates (2023-2035) Conservative Scenario (USD Million)
  • Table 24.63 Medical Exoskeleton Market, Forecasted Estimates (2023-2035), Optimistic Scenario (USD Million)
  • Table 24.64 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
  • Table 24.65 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.66 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.67 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.68 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
  • Table 24.69 Medical Powered Exoskeleton Market: Historical Trends (2018- 2022) and Forecasted Estimates (2023-2035)
  • Table 24.70 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.71 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.72 Medical Exoskeleton Market: Distribution by Form 2018, 2023 and 2035 (USD Million)
  • Table 24.73 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.74 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.75 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
  • Table 24.76 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.77 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.78 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
  • Table 24.79 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.80 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
  • Table 24.81 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
  • Table 24.82 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
  • Table 24.83 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
  • Table 24.84 Medical Exoskeleton Market in Asia-Pacific: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)
  • Table 24.85 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) Forecasted Estimates (2023- 2035)

List of Figures

  • Figure 2.1 Research Methodology: Research Assumptions
  • Figure 2.2 Research Methodology: Project Methodology
  • Figure 2.3 Research Methodology: Forecast Methodology
  • Figure 2.4 Research Methodology: Robust Quality Control
  • Figure 2.5 Research Methodology: Key Market Segmentations
  • Figure 4.1 Executive Summary: Medical Exoskeleton Market Landscape
  • Figure 4.2 Executive Summary: Partnerships and Collaborations
  • Figure 4.3 Executive Summary: Patent Analysis
  • Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 5.1 Types of Mobility Assistive Devices
  • Figure 5.2 Key Historical Events related to Exoskeleton
  • Figure 5.3 Classification of Exoskeleton
  • Figure 5.4 Applications of Exoskeleton
  • Figure 5.5 Movements Supported by Lower Body, Upper Body and Full Body Exoskeleton
  • Figure 5.6 Components of a Powered / Robotic Exoskeleton
  • Figure 5.7 Features of Exoskeleton
  • Figure 5.8 Limitations of Exoskeleton
  • Figure 6.1 Medical Exoskeleton: Distribution by Status of Development
  • Figure 6.2 Medical Exoskeleton: Distribution by Type of Body Part Covered
  • Figure 6.3 Medical Exoskeleton: Distribution by Mode of Operation
  • Figure 6.4 Medical Exoskeleton: Distribution Type of Body Part Covered and Mode of Operation
  • Figure 6.5 Medical Exoskeleton: Distribution by Form of Exoskeleton
  • Figure 6.6 Medical Exoskeleton: Distribution by Mode of Operation and Form of Exoskeleton
  • Figure 6.7 Medical Exoskeleton: Distribution Type of Body Part Covered and Form of Exoskeleton
  • Figure 6.8 Medical Exoskeleton: Distribution by Device Mobility
  • Figure 6.9 Medical Exoskeleton: Distribution by Mode of Operation and Device Mobility
  • Figure 6.10 Medical Exoskeleton: Distribution by Form of Exoskeleton and Device Mobility
  • Figure 6.11 Medical Exoskeleton: Distribution by Type of Body Part Covered and Device Mobility
  • Figure 6.12 Medical Exoskeleton: Distribution by User-Machine Interface
  • Figure 6.13 Medical Exoskeleton: Distribution by Type of Body Part Covered and User-Machine Interface
  • Figure 6.14 Medical Exoskeleton: Distribution by Mode of Operation and User-Machine Interface
  • Figure 6.15 Medical Exoskeleton: Distribution by Availability of Advanced Features
  • Figure 6.16 Medical Exoskeleton: Distribution by End User
  • Figure 6.17 Medical Exoskeleton: Distribution by Patient Age Group
  • Figure 6.18 Medical Exoskeleton: Distribution by Exoskeleton Setting for Patients
  • Figure 6.19 Medical Exoskeleton: Distribution by Breakthrough Designation
  • Figure 6.20 Medical Exoskeleton Companies: Distribution by Year of Establishment
  • Figure 6.21 Medical Exoskeleton Companies: Distribution by Company Size
  • Figure 6.22 Medical Exoskeleton Companies: Distribution by Company Size and Employee Count
  • Figure 6.23 Medical Exoskeleton Companies: Distribution by Location of Headquarters (Region)
  • Figure 6.24 Medical Exoskeleton Companies: Distribution by Location of Headquarters (Country)
  • Figure 6.25 Medical Exoskeleton Companies: Distribution by Company Size and Location of Headquarters
  • Figure 6.26 Medical Exoskeleton Companies: Distribution by Company Ownership
  • Figure 6.27 Medical Exoskeleton Companies: Distribution by Location of Headquarters and Company Ownership
  • Figure 6.28 Medical Exoskeleton Companies: Distribution by Additional Services Offered
  • Figure 6.29 Most Active Players: Distribution by Number of Medical Exoskeleton Location of Headquarters (Country)
  • Figure 7.1 Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
  • Figure 7.2 Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
  • Figure 7.3 Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
  • Figure 7.4 Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
  • Figure 7.5 Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
  • Figure 7.6 Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
  • Figure 7.7 Product Competitiveness Analysis: Full Body Medical Exoskeleton
  • Figure 8.1 CYBERDYNE: Annual Revenues, FY 2019 - FY 2023 (JPY Billion)
  • Figure 8.2 CYBERDYNE: Distribution of Revenues by Business Segment, FY 2021- FY 2022
  • Figure 8.3 Ekso Bionics: Annual Revenues, 2018 - Q1 2023 (USD Billion)
  • Figure 8.4 Ekso Bionics: Distribution of Revenues by Business Segment, FY 2023
  • Figure 8.5 Panasonic: Annual Revenues, FY 2018- FY 2023 (JPY Billion)
  • Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
  • Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
  • Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
  • Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
  • Figure 10.6 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Figure 10.7 Partnerships and Collaborations: Local and International Agreements
  • Figure 10.8 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
  • Figure 10.9 Most Active Players: Distribution by Number of Partnerships
  • Figure 11.1 Patent Analysis: Distribution by Type of Patent
  • Figure 11.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Pre-2016-2022
  • Figure 11.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, 2016-2022
  • Figure 11.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2016-2023
  • Figure 11.5 Patent Analysis: Distribution by Publication Time
  • Figure 11.6 Patent Analysis: Distribution by Patent Jurisdiction (Region)
  • Figure 11.7 Patent Analysis: Distribution by Patent Jurisdiction (Country)
  • Figure 11.8 Patent Analysis: Distribution by CPC Symbols
  • Figure 11.9 Patent Analysis: Distribution by Type of Applicant
  • Figure 11.10 Leading Industry Players: Distribution by Number of Patents
  • Figure 11.11 Leading Non-Industry Players: Distribution by Number of Patents
  • Figure 11.12 Leading Individual Assignees: Distribution by Number of Patents
  • Figure 11.13 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
  • Figure 11.14 Leading Non-Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
  • Figure 11.15 Patent Analysis: Distribution by Patent Age
  • Figure 11.16 Patent Analysis: Patent Valuation
  • Figure 12.1 Differences Between Red Ocean Strategy and Blue Ocean Strategy
  • Figure 12.2 Blue Ocean Strategy: Strategy Canvas
  • Figure 12.3 Blue Ocean Strategy: Pioneer- Migrator-Settler (PMS) Map
  • Figure 12.4 Blue Ocean Strategy: Buyer Utility Map
  • Figure 13.1 Market Drivers
  • Figure 13.2 Market Restrains
  • Figure 13.3 Market Opportunities
  • Figure 13.4 Market Challenges
  • Figure 14.1 Medical Exoskeleton Market, Historical Trends (2018-2022) and Future Estimates (2023-2035) (USD Million)
  • Figure 14.2 Medical Exoskeleton Market, Future Estimates (2023-2035), Base Scenario (USD Million)
  • Figure 14.3 Medical Exoskeleton Market, Future Estimates (2023-2035), Conservative Scenario (USD Million)
  • Figure 14.4 Medical Exoskeleton Market, Future Estimates (2023-2035), Optimistic Scenario (USD Million)
  • Figure 15.1 Medical Exoskeleton Market: Distribution by Body Part Covered, 2018, 2023 and 2035 (USD Million)
  • Figure 15.2 Medical Upper Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 15.3 Medical Lower Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023- 2035)
  • Figure 15.4 Medical Full Body Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 16.1 Medical Exoskeleton Market: Distribution by Mode of Operation, 2018, 2023 and 2035 (USD Million)
  • Figure 16.2 Medical Powered Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 16.3 Medical Passive Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 16.4 Medical Hybrid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 17.1 Medical Exoskeleton Market: Distribution by Form, 2018, 2023 and 2035 (USD Million)
  • Figure 17.2 Medical Rigid Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 17.3 Medical Soft Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 18.1 Medical Exoskeleton Market: Distribution by Device Mobility, 2018, 2023 and 2035 (USD Million)
  • Figure 18.2 Medical Fixed / Supported Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 18.3 Medical Mobile / Overground Walking Exoskeleton Market: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 19.1 Medical Exoskeleton Market: Distribution by End Users, 2018, 2023 and 2035 (USD Million)
  • Figure 19.2 Medical Exoskeleton Market by Patients: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 19.3 Medical Exoskeleton Market by Healthcare Professionals: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 20.1 Medical Exoskeleton Market: Distribution by Geography, 2018, 2023 and 2035 (USD Million)
  • Figure 20.2 Medical Exoskeleton Market in North America: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 20.3 Medical Exoskeleton Market in Europe: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 20.4 Medical Exoskeleton Market in Asia- Pacific: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 20.5 Medical Exoskeleton Market in Rest of the World: Historical Trends (2018-2022) and Future Estimates (2023-2035)
  • Figure 21.4 Concluding Remarks: Overall Medical Exoskeleton Market Landscape
  • Figure 21.3 Concluding Remarks: Partnerships and Collaborations
  • Figure 21.4 Concluding Remarks: Patent Analysis
  • Figure 21.5 Concluding Remarks: Market Forecast and Opportunity Analysis